Iopamiro

Iopamidol, the active ingredient in Iopamiro, is a iodinated contrast media presented as an injectable solution for intraarterial, intraarticular, intrathecal use. It enhances radiographic contrast during diagnostic imaging procedures, allowing clearer visualization of vascular and body cavity structures. GNH USA supplies Iopamiro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iopamiro, an iodinated contrast agent, is used in radiographic procedures that require enhanced visualization of vascular and body cavity structures. Angiography: improves delineation of blood vessels for diagnostic and interventional purposes. Arthrography: enhances joint space imaging to assess cartilage, ligaments, and intra‑articular pathology. Myelography: provides contrast for spinal canal evaluation, aiding detection of spinal lesions and nerve root compression.

Iopamiro may cause a range of adverse reactions following administration.

Common Side Effects: - Warmth or flushing sensation during injection. - Metallic taste or mild nausea. - Transient headache. - Mild urticaria or skin itching. - Temporary increase in blood pressure. - Mild vomiting.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal impairment, especially in patients with pre‑existing kidney disease. - Seizures or neurological disturbances. - Hypotension or cardiovascular collapse. - Cardiac arrest. - Pulmonary edema.

Before using Iopamiro, clinicians should consider several safety measures. - Assess renal function: evaluate serum creatinine and eGFR. - Review allergy history: identify prior iodine or contrast media reactions. - Use the lowest effective dose for the specific imaging study. - Monitor vital signs and patient response during and after injection. - Avoid in patients with known severe hypersensitivity to iodinated contrast agents. - Store at ambient temperature: keep in the original container, protect from moisture and direct light.

Iopamiro can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Metformin: increased risk of lactic acidosis in renal impairment. - Thyroid hormone therapy: excessive iodine load may affect thyroid function. - ACE inhibitors: heightened risk of contrast‑induced nephropathy.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate fluid and electrolyte imbalances. - NSAIDs: combined renal toxicity potential. - Beta‑blockers: possible hemodynamic alterations during contrast administration.